Specific coagulation impairment in patients with and without extracorporeal lung support during COVID-19-ARDS

• Conditions: J80.03; D68.01

• Registration Number: DRKS00025519
• Lead Sponsor: Klinik für Anästhesie und Intensivmedizin Universitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2021-06-06
• Study Start: 2021-06-08
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

severe COVID-19-ARDS

Exclusion Criteria

ECMO-therapy not indicated

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency and severity of acquired coagulation disorders such as acquired von Willebrand syndrome.

Secondary Outcome Measures

Name	Time	Method
Incidence of further coagulation disorders, mortality